Model
Edge
Ayala Pharmaceuticals Inc.
ADXS
Filing Type
425
Filing Date
12/1/2022
Updated
12/2/22, 9:51 AM
Copy Ref
Filing
425
Earnings Release
Exhibits
425
Prospectus Filed Pursuant to Rule 425
EX-3.1
EX-10.1